Hematology and Oncology: As presented at the 2019 American Society of Hematology (ASH) annual meeting, Bristol-Myers Squibb to seek FDA approval of liso-cel after pivotal B-cell lymphoma study hits main goals

https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-announces-liso-cel-met-primary-and-second